Quantitative determination of amorphous nicardipine hydrochloride in long acting formula (NIC-LA®) using light anhydrous silicic acid

Chemical and Pharmaceutical Bulletin

Volumn 52, Issue 12, 2004, Pages 1451-1457

  Kohinata, Takeru ^a,b   Fujii, Mitsuo ^a   Nakamura, Souichiro ^a   Hamada, Noritaka ^a   Yonemochi, Etsuo ^b   Terada, Katsuhide ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

Amorphous; Assay method; Differential scanning calorimetry; Light anhydrous silicic acid (LASA); Long acting preparation; Nicardipine hydrochloride

Indexed keywords

CARBOXYMETHYLCELLULOSE; EXCIPIENT; NIC LA; NICARDIPINE; SILICIC ACID; CALCIUM CHANNEL BLOCKING AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;

ARTICLE; CRYSTALLOGRAPHY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MATHEMATICAL PARAMETERS; MOLECULAR PHYSICS; PHYSICAL CHEMISTRY; QUANTITATIVE ANALYSIS; SUSTAINED RELEASE FORMULATION; CALIBRATION; CHEMISTRY; DELAYED RELEASE FORMULATION; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POWDER; X RAY DIFFRACTION;

CALCIUM CHANNEL BLOCKERS; CALIBRATION; CALORIMETRY, DIFFERENTIAL SCANNING; CARBOXYMETHYLCELLULOSE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; NICARDIPINE; POWDERS; SILICIC ACID; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 21644455084     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.52.1451     Document Type: Article

References (23)

1. Higuchi S., Shiobara Y., Xenobiotica, 10, 447-454 (1980).
2. Suzuki I., Sezaki H., "Iyakuhinnkaihatu," Vol. 14, Hirokawa, 1990, pp. 72-74.
3. Yuksel N., Tincer T., Baykara T., Int. J. Pharmaceut., 140, 145-154 (1996).
4. Yuksel N., Tincer T., Baykara T., Pharm. Dev. Techn., 3, 115-121 (1998).
5. Ozyazici M., Sevgi F., Ertan G., Drug Dev. Ind. Pharm., 23, 761-770 (1997).
6. Ohmura T., Kawata H., Aruga M., Sonobe T., Yoneya S., Sone C., JP. Patent No. 1272484, Oct. 19 (1981).
7. Shibahara T., Yono M., Shigetoh H., Takahashi T., JP. Patent No.2939069, Jun. 03 (1996).
8. Yonemochi E., Ueno Y., Ohmae T., Oguchi T., Nakajima S., Yamamoto K., Pharm. Res., 14, 798-803 (1997).
9. Ueno Y., Yonemochi E., Tozuka Y., Yamamura S., Oguchi T., Yamamoto K., J. Pharm. Pharmacol., 50, 1213-1219 (1998).
10. Yamaguchi T., Nishimura M., Okamoto R., Takeuchi T., Yamamoto K., Int. J. Pharm. Bull., 85, 87-96 (1992).
11. Robinson J. R., Lee V. H., "Controlled Drug Delivery, Fundamentals and Applications," Marcel Dekker, NewYork, 1987, p. 295.
12. Kitamura S., Miyamae A., Koda S., Morimoto Y., Int. J. Pharmaceut., 56, 125-134 (1989).
13. Nakai Y., Fukuoka E., Nakajima S., Hasegawa J., Chem. Pharm Bull., 25, 96-101 (1977).
14. Otsuka M., Kato F., Matsuda Y., AAPS Pharm. Sci., 2, Article 9 (2000).
15. Yoshikawa M., Hancock B. C., Zogrfi G., J. Pharm. Sci., 83, 1700-1705 (1994).
16. Saleki-Gerhardt A., Ahlneck C., Zografi G., Int. J. Pharmaceut., 101, 237-247 (1994).
17. Lusting C., Lennholm H., Iversen T., Nystrom C., Pharm. Res., 14, S-196 (1997).
18. Caporal-Gautier J., Nivet J. M., Algranti P., Guilloteau M., Histe M., Lallier M., N'Guyen-Huu J. J., Russotto R., STP Pharma Prat., 2, 205-226 (1992).
19. Iwanami M., Shibanuma T., Fujimoto M., Kawai R., Tamazawa K., Takenaka T., Takahashi K., Murakami M., Chem. Pharm. Bull., 27, 1426-1434 (1979).
20. Kwon H. K., Michael J. F., Norman L. H., J. Pharm. Sci., 74, 283-289 (1985).
21. Klug H. P., Alexane L. E., "X-Ray Diffraction Procedures for Polycrystalline and Amorphous Materials," 2nd Ed., John Willey & Sons, New York, 1974, p. 875.
22. Gordon M., Talor J. S., J. Appl. Chem., 2, 493-500 (1952).
23. Woo E. M., Yau S. N., Macromolecules, 30, 3626-3631 (1997).